Back to Annual Meeting Program

Objective: The aim of this study is a retrospective analysis of our experience in Laparoscopic Ventral Rectopexy (LVR) with biological mesh to assess the safety and the efficacy of this surgical treatment for Obstructed Defecation Syndrome (ODS).
Methods: Between July 2010 and November 2011, fifteen patients had LVR with biological mesh for symptomatic ODS with enterocele, recto-rectal prolapse and third degree rectocoele. All patients underwent preoperative anoscopy, colonoscopy and perineo-defecography. The operative technique was standardized and in all cases a biological mesh was used. No colon resection or Stapled Transanal Rectal Resection (STARR) was performed in association with LVR. ODS score and Symptom Severity Score (SSS) were both used in follow up to assess morbidity and efficacy of this surgical procedure.
Results: Perioperative morbidity was 6,6% (one patient required reintervention for ileal volvolus) with no mortality. No major and minor complication as sepsis , bleeding, fecal urgency and urinary retention were recorded. The median hospital stay was . No recurrence after a mean follow up period of 5,7 months was observed with good overall patient satisfaction. The mean ODS score was 18 preop vs 5 postop, SSS 16 vs 7.
Conclusion: In our experience LVR is a safe and effective procedure for treatment of ODS in selected patient. However for patient with internal rectal prolapse STARR procedure remains the gold standard. LVR is an innovative feasible technique for patients with ODS associated with complex pelvic disease.